Regeneron Pharmaceuticals, Inc.
ANTI-HUMAN PAPILLOMAVIRUS (HPV) ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF

Last updated:

Abstract:

The present invention provides antigen-binding proteins that specifically bind to an HLA-displayed human papillomavirus (HPV) peptide, and therapeutic and diagnostic methods of using those binding proteins.

Status:
Application
Type:

Utility

Filling date:

13 Aug 2020

Issue date:

6 Jan 2022